Published in Cancer Weekly, December 17th, 2002
Their results should help doctors in the future to determine which of their patients with non-small cell lung cancer (NSCLC) who have undergone surgery with curative intent are likeliest to suffer from recurrences or relapse of their cancer. Consequently, postsurgery treatments used to prevent recurrences or relapse of their cancer could potentially be targeted to this group of high-risk individuals. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.